Of all microorganisms in the human body, the largest and most complex population resides
in the gastrointestinal (GI) tract. The gut microbiota continuously adapts to the host …

Small intestinal bacterial overgrowth (SIBO) is a common, yet underrecognized, problem. Its
prevalence is unknown because SIBO requires diagnostic testing. Although abdominal …

Small intestinal bacterial overgrowth is defined as the presence of excessive numbers of
bacteria in the small bowel, causing gastrointestinal symptoms. This guideline statement …

Functional gastrointestinal disorders (FGIDs), currently known as disorders of gut–brain
interaction, are emerging microbiota–gut–brain abnormalities that are prevalent worldwide …

In the clinical setting, small intestinal bacterial overgrowth (SIBO) is a frequent, but under-
diagnosed entity. SIBO is linked to various gastrointestinal (GI) and non-GI disorders with …

Bacterial overgrowth in the small intestine (SIBO) is a pathological growth of the intestinal
microbiota in the small intestine that causes clinical symptoms and can lead to digestive and …

Sleep disturbances often result from inappropriate lifestyles, incorrect dietary habits, and/or
digestive diseases. This clinical condition, however, has not been sufficiently explored in this …

Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease associated with the
pathological accumulation of lipids inside hepatocytes. Untreated NAFL can progress to non …

As a class of the commonly used drugs in clinical practice, non-steroidal anti-inflammatory
drugs (NSAIDs) can cause a series of adverse events including gastrointestinal injuries …

Following acute gastroenteritis (AGE) due to bacteria, viruses, or protozoa, a subset of
patients develop new onset Rome criteria positive irritable bowel syndrome (IBS), called …